Adrienne Frazior discusses the growing legal and regulatory risks hospitals face when controlled substance diversion incidents are not promptly identified, documented and investigated. She highlights common compliance shortcomings, including inadequate recordkeeping, delayed reporting, weak diversion prevention programs and insufficient internal controls, all of which can increase exposure to enforcement actions and litigation. Frazior emphasizes that health care organizations can strengthen their legal defensibility by maintaining robust compliance programs, conducting timely internal investigations and engaging experienced legal counsel as soon as a diversion event is suspected.

(subscription required)